Key Record Dates
ClinicalTrials.gov Identifier: | NCT04502862 |
---|---|
Brief Title: | A Phase 4, Randomized, Double-blind, Placebo-controlled,Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma (MORPHEO) |
First Submitted : | August 4, 2020 |
First Submitted that Met QC Criteria : | August 4, 2020 |
First Posted : | August 6, 2020 |
Last Update Submitted that Met QC Criteria : | January 25, 2024 |
Last Update Posted : | January 26, 2024 |